Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Cash from Investing Activities (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Cash from Investing Activities for 3 consecutive years, with -$233.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 1382.15% year-over-year to -$233.9 million, compared with a TTM value of -$305.1 million through Dec 2025, down 117.55%, and an annual FY2025 reading of -$305.1 million, down 117.55% over the prior year.
  • Cash from Investing Activities was -$233.9 million for Q4 2025 at BrightSpring Health Services, down from -$23.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$15.8 million in Q4 2024 and bottomed at -$233.9 million in Q4 2025.
  • Average Cash from Investing Activities over 3 years is -$48.3 million, with a median of -$27.6 million recorded in 2024.
  • Peak annual rise in Cash from Investing Activities hit 59.71% in 2025, while the deepest fall reached 1382.15% in 2025.
  • Year by year, Cash from Investing Activities stood at -$17.0 million in 2023, then rose by 7.3% to -$15.8 million in 2024, then plummeted by 1382.15% to -$233.9 million in 2025.
  • Business Quant data shows Cash from Investing Activities for BTSG at -$233.9 million in Q4 2025, -$23.8 million in Q3 2025, and -$23.2 million in Q2 2025.